C. Capone

Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes

David Olmos, David Lorente, Daniel Alameda et al. · Annals of Oncology · 2024 · 73 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database

Nicolas H. Thurin, Magali Rouyer, Marine Gross‐Goupil et al. · Cancer Epidemiology · 2020 · 35 citations · Full text

Medicine, Oncology, Urology +11

BRCA1/2 and homologous recombination repair alterations in high- and low-volume metastatic hormone-sensitive prostate cancer: prevalence and impact on outcomes

D. Olmos, D. Lorente, A. Jambrina et al. · Annals of Oncology · 2025 · 18 citations · Full text

Medicine, Oncology, Urology +14

Presence of somatic/germline homologous recombination repair (HRR) mutations and outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) receiving first-line (1L) treatment stratified by BRCA status.

David Olmos, David Lorente, Daniel Alameda et al. · Journal of Clinical Oncology · 2023 · 17 citations

Medicine, Oncology, Urology +17